GDF15 is an anorectic hormone that signals organismal stress to the brain. New data suggest that GDF15 enhances tolerance to acute inflammation by modulating liver lipid metabolism and triglyceride availability in mice.
References
O’Rahilly, S. Cell Metab. 26, 807–808 (2017).
Tsai, V. W. W., Husaini, Y., Sainsbury, A., Brown, D. A. & Breit, S. N. Cell Metab. 28, 353–368 (2018).
Hsu, J. Y. et al. Nature 550, 255–259 (2017).
Yang, L. et al. Nat. Med. 23, 1158–1166 (2017).
Emmerson, P. J. et al. Nat. Med. 23, 1215–1219 (2017).
Mullican, S. E. et al. Nat. Med. 23, 1150–1157 (2017).
Johnen, H. et al. Nat. Med. 13, 1333–1340 (2007).
Luan, H. H. et al. Cell 178, 1231–1244.e11 (2019).
Santos, I. et al. Preprint at bioRxiv https://doi.org/10.1101/613901 (2019).
Patel, S. et al. Cell Metab. 29, 707–718.e8 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.O.R. is an employee of the University of Cambridge and has provided remunerated consultancy services to the following pharmaceutical companies with an active or potential interest in GDF15: Pfizer, AstraZeneca, MedImmune and Novo-Nordisk. S.M.L. has no relevant conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Lockhart, S.M., O’Rahilly, S. The wasting hormone GDF15 frees up fat to fight infection. Nat Metab 1, 935–936 (2019). https://doi.org/10.1038/s42255-019-0131-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-019-0131-y
- Springer Nature Limited
This article is cited by
-
Serum growth differentiation factor-15 (GDF-15) is a biomarker of cardiac manifestations in children with COVID-19
European Journal of Medical Research (2023)